The Silence of the Bioethicists
By Leigh Turner,
Impact Ethics
| 03. 24. 2014
Last week, Kirstin Borgerson, a philosopher at Dalhousie University, published a
thoughtful commentary on my colleague Carl Elliott’s
persistent call for an investigation of Dan Markingson’s death and psychiatric research misconduct at the University of Minnesota. Dan Markingson was a young man from St. Paul who
committed suicide by nearly decapitating himself while enrolled in a psychiatric drug study at the University of Minnesota Medical Center, Fairview.In analyzing the audience’s response to Carl’s public lecture, alongside the typical response of her undergraduate students, Borgerson notes that there was no animated discussion of ethical issues in the Markingson case because “very simply, there is nothing to debate.” Borgerson adds,
Among serious scholars, there is no defense of the practice of: radically violating informed consent …; enrolling suicidal patients in the sort of risky trial that Markingson was enrolled in; having researchers disrespect and disregard concerns raised by family members about the well-being of research subjects during a trial; or creating conditions under which researchers are motivated to enroll subjects so as not to lose out on tens of thousands of...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Eric Schmidt, TIME | 04.16.2024
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...